+Search query
-Structure paper
Title | A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations. |
---|---|
Journal, issue, pages | Cell Rep, Vol. 36, Page 109433-109433, Year 2021 |
Publish date | Dec 1, 2020 (structure data deposition date) |
Authors | Bertoglio, F. / Fuhner, V. / Ruschig, M. / Heine, P.A. / Abassi, L. / Klunemann, T. / Rand, U. / Meier, D. / Langreder, N. / Steinke, S. ...Bertoglio, F. / Fuhner, V. / Ruschig, M. / Heine, P.A. / Abassi, L. / Klunemann, T. / Rand, U. / Meier, D. / Langreder, N. / Steinke, S. / Ballmann, R. / Schneider, K.T. / Roth, K.D.R. / Kuhn, P. / Riese, P. / Schackermann, D. / Korn, J. / Koch, A. / Chaudhry, M.Z. / Eschke, K. / Kim, Y. / Zock-Emmenthal, S. / Becker, M. / Scholz, M. / Moreira, G.M.S.G. / Wenzel, E.V. / Russo, G. / Garritsen, H.S.P. / Casu, S. / Gerstner, A. / Roth, G. / Adler, J. / Trimpert, J. / Hermann, A. / Schirrmann, T. / Dubel, S. / Frenzel, A. / Van den Heuvel, J. / Cicin-Sain, L. / Schubert, M. / Hust, M. |
External links | Cell Rep / PubMed:34273271 |
Methods | X-ray diffraction |
Resolution | 2 Å |
Structure data | PDB-7b3o: |
Chemicals | ChemComp-HOH: |
Source |
|
Keywords | ANTIVIRAL PROTEIN / neutralizing antibodies / SARS-CoV-2 / RBD |